Antimicrobials review
This article was originally published in The Tan Sheet
Executive Summary
FDA Anti-Infective Drugs Advisory Committee will discuss microbiologic endpoints as surrogates for efficacy in clinical trials designed to address the safety and efficacy of antiseptic health care drug products, the agency announces. Meeting will be held May 11 at the Holiday Inn in Gaithersburg, Md. Those wishing to make a formal presentation should contact Tara Turner at [email protected], FDA says. Trials could impact OTC antimicrobials. The Cosmetic, Toiletry & Fragrance Association and Soap & Detergent Association have urged the agency to use their proposed test methods to evaluate efficacy of finished topical antimicrobials in the OTC Antiseptic Health Care Final Monograph...
You may also be interested in...
Antiseptic meeting
Anti-infective Drugs Advisory Committee meeting scheduled for May 11 has been cancelled, according to committee hotline. Panelists were to discuss microbiologic endpoints as substitutes for effectiveness in clinical trials intended to address the safety and efficacy of antiseptic health care drug products (1"The Tan Sheet" March 22, 2004, In Brief). FDA has not announced a new date for the meeting...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.